How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries

• Váldodahkkit: Alessandra Blonda (Dahkki), Yvonne Denier (Dahkki), Isabelle Huys (Dahkki), Pawel Kawalec (Dahkki), Steven Simoens (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction: The expansion of orphan drug treatment at increasing prices, together with uncertainties regarding their (cost-)effectiveness raises difficulties for decision-makers to assess these drugs for reimbursement. The present qualitative study aims to gain better insight into current value as...